American distribution service company Chindex International of Bethesda, MD, last month signed a letter of intent with China’s Ministry of Public Health for the purchase of up to $15 million of medical equipment. The agreement arises out of
American distribution service company Chindex International of Bethesda, MD, last month signed a letter of intent with Chinas Ministry of Public Health for the purchase of up to $15 million of medical equipment. The agreement arises out of collaboration between Chinas Ministry of Health Foreign Loan Office, its Ministry of Foreign Trade and Economic Cooperation, and its State Planning Commission, as well as the U.S. Department of Commerce and the U.S. Export-Import Bank.
The transaction depends on a loan guarantee from the U.S. Export-Import Bank. It is Chindexs second loan project with the bank for U.S. medical equipment. In 1996, the firm provided $8.4 million worth of equipment to Chinese hospitals. The most recent deal includes ultrasound scanners from Acuson, bone densitometers from Lunar, transmyocardial revascularization lasers from PLC, cardiac catheterization imaging systems from Trex Medical/XRE, and clinical laboratory equipment from Johnson & Johnson Clinical Diagnostics and Nova Biomedical.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.